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ABSTRACT
Andropause, the culminating phase of male ageing, is characterized by deregulation of the hypothalamic-pituitary-
gonadal axis and low circulating free testosterone. The aim of this study was to investigate the immunohistomorphometric 
characteristics of the pituitary gonadotropic i.e. follicle-stimulating hormone (FSH) and the luteinizing hormone (LH) 
producing cells after testosterone application in a rat model of the andropause. Middle-aged Wistar rats were divided into 
orchidectomized (ORX; n=8) and testosterone treated orchidectomized (ORX+T; n=8) groups. Testosterone propionate (5 
mg/kg b.m. /day) was administered for three weeks, while the ORX group received the vehicle alone. Immunohistochemically 
stained FSH and LH cells underwent morphometric and optical density-related analysis, while circulating concentrations 
of the sex steroids were measured by immunoassays. Serum concentrations of testosterone and estradiol were significantly 
(p<0.05) increased by 24 and 2.7 fold respectively, compared to the ORX group. The volume of FSH and LH cells was 
significantly (p<0.05) decreased by 51.3% and 56.6% respectively, in comparison with ORX rats. Relative volume density 
of FSH and LH cells was also significantly (p<0.05) decreased by 54.0% and 72.8% respectively, compared to the ORX 
group. Results related to the optical density of gonadotropic cells (reflecting their hormonal content) were in line with 
the morphometric findings i.e. this parameter of FSH and LH cells was significantly (p<0.05) decreased by 25.7% and 
16.2% respectively, in comparison with ORX rats. Conclusion: In conclusion, applied testosterone increased the serum 
concentrations of sex steroids, as well as it decreased morphometric parameters and optical density of gonadotropic cells in 
ORX rats.
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INTRODUCTION
The complex phenomenon of ageing in males, 
which implies a temporal, psychophysiological 
and social dimension, is progressive and 
gradual in its essence, and culminates in a 
point of entry into andropause (1, 2, 3) i.e. the 
specific multi-symptomatic syndrome that is 
substantially characterized by deregulation of the 
hypothalamic-pituitary-gonadal (HPG) axis (4). 
Free testosterone deficiency, which grounds the 
hormonal milieu of the ageing male, represents 
the consequence of numerous and multilevel 
alterations. When it comes to testicular Leydig 
cells, lowered activity of a certain steroidogenic 
enzymes or increase in cyclooxygenase-2 activity 
and its tonic inhibition of steroidogenic acute 
regulatory gene expression are observable (5). 
Also, some studies with aged rats suggested the 
existence of hypothalamic-pituitary dysfunction 
characterized by a reduction in the gonadotrophin 
releasing hormone (GnRH) impulse from the 
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hypothalamus and a decrease in the amplitude of 
the luteinizing hormone (LH) secretory pulse (6, 
7). In conjunction with these results, Elmilinger 
et al. (8) reported a significant increase for 
pituitary follicle-stimulating hormone (FSH) 
and luteinizing hormone (LH) serum levels with 
ageing in men, which may indicate the long-term 
feedback effect of low testosterone (9).
Testosterone supplementation in andropause 
seems to be an approach of choice in the 
symptomatic approach (10, 11), although a 
considerable monitoring for efficacy and safety is 
advised (12). Furthermore, circulating levels of LH 
and FSH were shown to be significantly decreased 
during dihydrotestosterone treatment of ageing 
men (13), while applied testosterone supressed the 
pulsatile LH and FSH secretion in castrated rats (14). 
Testosteron regulates the gonadotrope cell function 
by a negative feedback effect, achieved at the level 
of the hypothalamus and pituitary gonadotropic 
cells directly, where the expression of androgen 
receptors was found (15). We hypothesised that the 
immunohistomorphometric properties of pituitary 
gonadotropic cells (FSH and LH producing, the 
specific operative units of HPG axis) may change 
after testosterone application to ageing male rats, 
so the aim was to visualize a phenomenology of 
the potential change by using available microscopic 
methodology.
Therefore, the immunohistomorphometric 
properties of the FSH and LH cells were in our 
focus, in an animal model of the andropause. 
Orchidectomized middle-aged rats, in which 
both testicular testosterone and estradiol are 
eliminated from the hormone milieu, were used 
in order to mimic the andropause. In parallel, 
this experimental set up fits into an established 
approach for examining the potential effects of 
synthetic steroids/steroid-like compounds on 
endocrine homeostasis (16 - 19).
MATERIAL AND METHODS
Animals and experiment design
The experiments involved 16-month-old 
(middle-aged) Wistar rats. They were bred in 
the Institute for Biological Research “Siniša 
Stanković”, Belgrade, Serbia; housed one per 
cage and maintained under constant laboratory 
conditions (22±2ºC, 12-12 h light-dark cycle), with 
free access to food (standard diet; the chemical 
composition given in Table 1) and water.
Table 1. Chemical composition of the rat diet used 
in the experiment
Chemical composition
Metabolizable energy 11000 kJ/kg
Protein, min 20%
Moisture, not more than 13%
Ash, not more than 10%
Cellulose, not more than 8%
Calcium, min 1%
Lysine, min 0.90 %
Methionine + Cystine,  
min 0.75 %
Phosphorus, min 0.50 %
Sodium 0.15-0.25 %
Vitamin A, min 10 000 IU/kg
Vitamin D3, min 1600 IU/kg
Vitamin E, min 25 mg/kg
Vitamin B12, min 0.02 mg/kg
Zinc, min 100 mg/kg
Iron, min 100 mg/kg
Manganese, min 30 mg/kg
Copper, min 20 mg/kg
Iodine, min 0.5 mg/kg
Selenium, min 0.1 mg/kg
Antioxidant, min 100 mg/kg
 
At the age of 15 months, experimental animals 
were randomly bilaterally orhidectomized (ORX; 
n=16 animals) under Ketamine anesthesia (15mg/kg 
b.m.; Richter Pharma, Wels, Austria). The recovery 
period lasted two weeks. Orchidectomized rats were 
then divided into two groups of eight animals (n=8) 
each. The first group was subcutaneously treated 
with testosterone propionate (Fluka Chemie AG, 
Buchs, Switzerland; ORX+T), in a dose of 5 mg/
kg b.m. (19, 25-26) every day except on Sundays, 
for 3 weeks. The final injected volume was 0.5 ml 
per animal. The second orchidectomized group 
(ORX) was given the same volume (0.5 ml) of 
vehicle (sterile olive oil) alone, and they served 
as controls. Body mass, from these two groups 
after the treatment, was measured. All the animals 
(n=16) were sacrificed by decapitation under ether 
anesthesia (ether ad narcosis Ph. Iug. III., Lek, 
Ljubljana, Slovenia), 24 h after the last injection.
Testosterone effect on gonadotropic cells in andropaused rat
7
All experimental procedures were in 
compliance with Directive 2010/63/EU on the 
protection of animals used for experimental and 
other scientific purposes and was approved by 
the Ethical Committee for the Use of Laboratory 
Animals of the Institute for Biological Research 
“Siniša Stanković”, University of Belgrade, Serbia. 
Hormonal analyses
Blood was collected from the trunk and 
separated sera samples of all animals were stored 
at the same time at -70°C until assayed. Serum 
testosterone concentrations were determined 
without dilution, using the competitive 
immunoenzymatic colorimetric method (EIAgen 
Testosterone Kit; Adaltis Italia S.p.A., Bologna, 
Italy), which sensitivity is 0.01 ng/ml, with an intra-
assay coeficient of variation (CV) of 6.2%. Serum 
estradiol concentrations were measured without 
dilution, using the electrochemiluminescence 
immunoassay (ECLIA, Roche, Basel, Switzerland), 
which low detection limit is 5.0 pg/ml, with an 
intra-assay CV of 6.2%.
Light microscopy and immuno-histochemistry
After sacrificing, excised and weighed 
pituitaries were fixed in 4% paraformaldehyde 
for 24 h, dehydrated in a series of increasing 
concentrations of ethanol, enlightened in xylol and 
embedded in paraplast. Serial, 5-µm thick pituitary 
tissue sections were obtained using LEICA RM 
2125RT rotational microtome (Leica Biosystems 
Nussloch GmbH, Nussloch, Germany), then 
deparaffinised in xylol and rehydrated in a series of 
decreasing concentrations of ethanol. For the light 
microscopy analysis, gonadotropic- (FSH- and LH- 
producing) cells were immunolabeled using the 
peroxidase-antiperoxidase complex (PAP) method 
(20, 21). After rehydration of the pituitary sections, 
the endogenous peroxidase activity was blocked by 
the incubation in 9 mmol (0.3%) hydrogen peroxide 
solution in methanol, for 15 min at 24°C. Before 
the application of the specific primary antisera, 
nonspecific background staining was prevented 
by incubation of the sections with nonimmune, i.e. 
normal swine serum, diluted (1:10) with phosphate 
buffered saline (PBS) pH 7.4, for 45 min at 24°C. 
Pituitary sections were then overlaid with the 
appropriate dilutions of the specific primary 
antibodies, namely polyclonal anti-rat βFSH (1:300) 
and βLH (1:500), for 24 h at 4°C. Antisera to rat 
βFSH (NIDDK-anti-rBeta FSH-IC1, Lot#AFP-7798 
1289P) and βLH (NIDDK-anti-rBeta LH-IC, 
Lot#AFP-C697071P) were obtained from Dr. A. 
F. Parlow, National Hormone Peptide Program 
(NHPP), Harbor-UCLA Medical Centre, Carson, 
CA, USA. The specificities of these antisera were 
assessed by the NIDDK. After washing in PBS, the 
sections were incubated with secondary antibody 
polyclonal swine-anti-rabbit IgG/HRP (Dako 
A/S, Glostrup, Denmark). Binding sites were 
visualized using 0.05% diaminobenzidine (DAB, 
Serva, Heidelberg, Germany) and 0.03% hydrogen 
peroxide in 0.2M TRIS-HCl buffer, pH 7.4. The 
sections were counterstained with hematoxylin 
and mounted in Canada balsam (Molar Chemicals 
KFT, Budapest, Hungary). For the negative control 
pituitary sections, the primary antibody was 
omitted and replaced by PBS.
Digital images of the pituitary gland 
immunolabeled sections were taken using a LEITZ 
DM RB light microscope (Leica Mikroskopie & 
Systems GmbH, Wetzlar, Germany), a LEICA 
DFC320 CCD camera (Leica Microsystems Ltd., 
Heerbrugg, Switzerland) and the Leica DFC Twain 
Software (Leica, Germany). 
Morphometry
Morphometrical measurements were performed 
as described previously (16-18). Namely, two 
pituitary sections (5-µm thick) from the superior, 
three from the middle and two from the inferior 
part (seven horizontal sections) of the rat pituitary 
glands were analysed. The point counting method 
was used at an overall magnification of x1000. The 
M42 multipurpose test grid, inserted into the ocular 
of a Zeiss light microscope (Jena, Germany), was 
randomly positioned on the pituitary section at 
the beginning of counting. Counting was carried 
out on the following 50 test fields per section. 
Average values were calculated per pituitary i.e. 
per animal (7 sections, 350 test fields) and eight 
pituitaries were analysed per group. Cell volume 
(Vc, μm3) and relative volume density (percentage 
of immunopositive cells in mm3; VVC, %) were 
determined for FSH- and LH-immunopositive cells.
The following parameters were counted:
Pn - number of points hitting on nuclei of immuno-
histochemically labeled cells inside the test 
field
Ptc - number of points hitting on cytoplasm of 
immuno-histochemically labeled cells inside 
the test field
Nn - number of immuno-histochemically labeled 
cell nuclei inside the test field.
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The formula for calculating the cell volume was:
Vc = 1/NV , where
NV is the numerical density of FSH and LH cells. 
Nuclei volume density (VVn) provides information 
about nuclei attendance in the estimated cells and is 
calculated as follows:
VVn = ΣPn/ΣPtc
Since rat FSH and LH cells are mononuclear, 
NV corresponds to the number of cells per cubic 
millimetre, according to the formula:
NV = (k/β) (NA3/2 / VVn½)
On the basis of earlier karyometric studies 
(22), the shape coefficient β for pituitary cells was 
estimated to be 1.32, where k is a factor related to 
cell distribution according to their size (in the case 
of FSH and LH cells its value is 1) and NA is the 
number of cells in the plane of the pituitary tissue 
section. NA is calculated as follows:
NA = ΣNn/ΣPtc·a ,
where a represents the rhombic area belonging 
to every point of the test system and is calculated 
using the formula:
a = d2 31/2/2 ,
where d is the test line length in the test system 
employed.
Relative volume density (VVC) is calculated as 
the ratio of the sum of Pn and Ptc (Pn+Ptc) and the 
total number of points in the test system. Since a 
test system with 42 points was used and parameters 
were calculated using 50 test fields, the definite 
formula was:
VVC = (Pn+Ptc)/ 50·42
Optical density measurements
The Windows based ImageJ program (Image J, 
version 1.50f) was used for the analysis of optical 
density that reflects the gonadotropic cell hormonal 
content. Namely, 30 unbiasedly captured images 
(the microscopic tool has already been described: 
2088 x 1550 pixels, 63x objective magnification) 
per gonadotropic cell (FSH or LH) specific-
immunostained pituitary per animal were analysed. 
Initially, the spectral deconvolution method of 
3,3′-diaminobenzidine tetrahydrochloride (DAB)/
Hematoxylin color spectra was performed, using 
optimized optical density vectors of the color 
deconvolution plug-in for adequate separation of 
the DAB color spectra. To determine the optical 
density for the red, green and blue (RGB) channel 
of Hematoxylin and DAB, we kept the protocol 
previously described by Ruifrok and Johnston (23) 
and Varghese et al. (24). Since the optical density 
is proportional to the concentration of the stain in 
gonadotropic cells, the amount of stain present is 
a factor determining the optical density (OD) at a 
wave length specific to the stain, according to the 
formula:
OD = – log10 (IC/I0.C),
IC is the intensity of detected light after passing 
through a specimen and I0.C refers to the intensity 
of light entering the specimen.
Statistical analysis
STATISTICA® version 7.0 (StatSoft, Inc) was 
used for the statistical analysis. Hormonal and 
morphometric data obtained from each group 
were statistically evaluated by the Student s´ t-test. 
A probability value of 5% or less was considered 
statistically significant. The data are presented as 
means ± SD.
RESULTS
Body mass and pituitary weights
Data for the body mass and absolute/relative 
pituitary weights are summarized in Table 2. It is 
obvious that orchidectomy, as well as subsequent 
treatment with testosterone did not cause 
statistically significant changes in the measured 
parameters.
Table 2. Body mass, absolute and relative pituitary weights in orchidectomized (ORX) and testosterone treated 
orchidectomized (ORX+T) middle-aged rats
Experimental group Body mass after the treatment (g)
Absolute pituitary weight 
(mg)
Relative pituitary weight 
(mg%)
ORX 670 ± 14 16.50 ± 0.01 2.47 ± 0.38
ORX+T 688 ± 65 17.00 ± 0.01 2.42 ± 0.43
All values are the means ± SD, n = 8 animals per group
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Figure 1. Serum level of testosterone (A) and estradiol (B) in orchidectomized (ORX) and testosterone treated 
orchidectomized (ORX+T) middle-aged rats. All values are provided as the mean ± SD, n = 8 animals per group; 
*p<0.05 vs. ORX rats
Figure 2. FSH- (A) and LH- (B) immunoreactive cells in the pituitary pars distalis from orchidectomized (ORX) 
and testosterone treated orchidectomized (ORX+T) middle-aged rats (objective magnification 40x, bar = 25μm)
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Hormonal data
The serum hormonal levels are shown in Figure 
1. In ORX+T group, circulating testosterone and 
estradiol were significantly (p<0.05) increased by 
24 and 2.7 fold respectively, compared to the ORX 
group values (Figure 1A and B).
Immuno-histochemical findings
Gonadotropic cells (FSH and LH) in ORX 
rats were widespread throughout the pars 
distalis, in groups or as single cells often in 
close contact with blood capillaries. They were 
hypertrophic, predominately oval in shape, with 
prominent eccentrically located nuclei. Strong 
immunopositivity of FSH and LH cells was 
observed. After the treatment with testosterone, 
gonadotropic cells were significantly smaller in 
size and less numerous (Figure 2A and B).
Morphometric and optical density-related results
The morphometric and optical density 
parameters observed for the FSH and LH cells in 
this study are represented in Figure 3. Namely, in 
ORX+T rats the volume of FSH and LH cells (Vc) 
was significantly (p<0.05) decreased by 51.3% and 
56.6% respectively, in comparison with the ORX 
animals (Figure 3A). The relative volume density 
(Vvc) of FSH and LH cells in ORX+T animals was 
significantly (p<0.05) decreased by 54.0% and 
72.8% respectively, compared to the ORX group 
(Figure 3B). Optical density of FSH and LH cells 
after orchidectomy and testosterone treatment was 
significantly (p<0.05) decreased by 25.7% and 
16.2% respectively, in comparison with ORX rats 
(Figure 3C).
DISCUSSION
In the present study, we investigated the 
effects of testosterone application on the 
immunohistomorphometric properties of pituitary 
FSH and LH cells in a rat model of the andropause, 
adequately represented with orchidectomized 
middle-aged rats. By performing orchidectomy, 
Figure 3. (A) Cellular volume (Vc, μm3), (B) relative volume density (Vvc, %) and (C) optical density of FSH and 
LH cells in orchidectomized (ORX) and testosterone treated orchidectomized (ORX+T) middle-aged rats. All values 
are provided as the mean ± SD, n = 8 animals per group. *p<0.05 vs. ORX rats
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any testicular inputs on the HPG axis were avoided, 
which defines the optimal space for examining 
the potential effects of synthetic steroids on the 
endocrine homeostasis (19, 25, 26). The dose of 
testosterone employed (5 mg/kg b.m.) has already 
performed some bone protection and stress 
hormone secretion-related beneficial effects in 
the same male rats (19, 25, 26). Our aim was to 
visualize a phenomenology of changes at the 
level of specific HPG axis operative units, upon 
application of a beneficial dose of testosterone 
to andropausal rats, by exploiting the available 
microscopic methodology.
In our experiment, applied testosterone 
expectedly increased the serum concentration of 
testosterone, but raised the circulating estradiol 
as well. It seems that the considerable aromatase 
activity (converts androgens into estrogens) is 
displaced outside the testes in andropausal rats, 
given that Leydig cells as the important source of 
aromatase (27) are surgically eliminated herein.
In orchidectomized rats, gondotropic (FSH and 
LH) cells are hypertrophied and enlarged, which 
could be explained by increased stimulation by 
GnRH (28). Increased serum levels of testosterone 
and estradiol in our study led to the recovery of 
hyperstimulated gonadotropes, confirmed at the 
histological level by detection of smaller and less 
numerous FSH and LH cells. Also, the volume, 
volume density and optical density (reflecting 
the hormonal content) of gonadotropic cells were 
significantly reduced. Our results confirmed that 
sex steroids regulate gonadotropic cell function 
by negative feedback effect. At the level of 
hypothalamus, sex steroids provide a recovery of 
the GnRH content in ORX male mice and indicate 
that androgen and estrogen signaling pathways can 
regulate the GnRH content in castrated males (29). 
Expression of androgen and estrogen receptors in 
FSH and LH cells in rats suggests a direct action of 
sex steroids at the gonadotropic cell level (15, 30). 
Whether they act at the hypothalamic or pituitary 
levels or both, testosterone and estradiol suppress 
FSH and LH cell function (29).
CONCLUSION
In conclusion, we have demonstrated that the 
exposure of orchidectomized rats to testosterone 
causes the reduction of volume, relative volume 
density and optical density of gonadotropic 
cells, while it increases serum concentrations of 
testosterone and estradiol. These changes indicate 
a potent effect of synthetic testosterone on the 
function of HPG system and endocrine homeostasis 
in males.
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